| David E Long, PHARMD | |
|
11670 Atwood Rd, Auburn, CA 95603-9522 | |
| (530) 887-2836 | |
| (530) 887-2842 |
| Full Name | David E Long |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 11670 Atwood Rd, Auburn, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356597967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 27295 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David E Long, PHARMD 11670 Atwood Rd, Auburn, CA 95603-9522 Ph: (530) 887-2836 | David E Long, PHARMD 11670 Atwood Rd, Auburn, CA 95603-9522 Ph: (530) 887-2836 |
News Archive
MESA Group Holdings, a Pantheon Healthcare Group company, today announced the acquisition of French diagnostic imaging service provider Sigil. Complementing MESA's recent business expansion into France with its core Multi-Vendor Service (MVS) and Managed Equipment Service (MES) offerings, the acquisition of Sigil will accelerate the development and adoption of more efficient asset management and medical equipment maintenance service solutions for public and private sector hospitals and imaging centres.
The Arkansas Supreme Court reversed a $1.2 billion judgment against Johnson & Johnson on Thursday, finding that the state attorney general erred by suing under a law that applied to health care facilities, not drug companies. The judgment, one of the largest in history for a state fraud case, was imposed in 2012 after a jury concluded that Johnson & Johnson had improperly marketed and concealed the risks of Risperdal, an antipsychotic drug (Thomas, 3/2).
Comba Telecom Inc., a leading wireless solutions provider, announced it has successfully completed the implementation of a turnkey 3G and 4G LTE wireless solution for a hospital located in Indiana.
Combining intratumoral electroporation of interleukin-12 (IL-12) DNA (tavokinogene telseplasmid, or TAVO) with the immune checkpoint inhibitor pembrolizumab (Keytruda) led to clinical responses in patients with immunologically quiescent advanced melanoma, according to results from a phase II trial.
› Verified 8 days ago
John Frank Ayres, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 Bell Rd, Auburn, CA 95603 Phone: 530-823-8125 Fax: 530-823-8179 | |
Thuong Hoang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Bell Rd # 95603, Auburn, CA 95603 Phone: 530-889-5650 | |
Da Kang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 388 Elm Ave, Auburn, CA 95603 Phone: 530-823-0825 | |
May Goto, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2700 Bell Rd, Auburn, CA 95603 Phone: 530-889-2766 | |
Janine Mary Hackland, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 420 Grass Valley Hwy, Auburn, CA 95603 Phone: 530-823-0558 | |
Yvonne Chih Cunningham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2550 Bell Rd, Auburn, CA 95603 Phone: 530-401-9979 | |
Viktoriya Ioffe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12120 New Airport Rd, Auburn, CA 95603 Phone: 530-888-9235 |